3B BlackBio Dx Ltd approves Q2 and H1 FY27 results, with consolidated Q2 revenue of ₹48.28 crore and net profit of ₹18.02 crore
- Consolidated Q2 revenue rose 42.4% year on year and 44.2% sequentially; net profit increased 19.8% and 100.6%, respectively.
- Consolidated Q2 operating margin was approximately 40.7%; standalone revenue and net profit were ₹36.51 crore and ₹17.96 crore.
- No exceptional items were reported; the limited review identified no matter indicating material misstatement. Subsidiary results were based on unaudited management information.
